{"organizations": [], "uuid": "c92fb933ddc13ff66b5c7711783499bd8ad1353a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 99, "shares": 99, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources/r/?m=02&d=20180426&t=2&i=1255607125&w=1200&r=LYNXMPEE3P17S", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/us-monsanto-m-a-bayer/bayer-monsanto-deal-on-track-for-u-s-approval-by-end-of-may-source-idUSKBN1HX1UX", "country": "US", "domain_rank": 408, "title": "Bayer, Monsanto deal on track for U.S. approval by end of May -source", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-26T15:01:00.000+03:00", "replies_count": 0, "uuid": "c92fb933ddc13ff66b5c7711783499bd8ad1353a"}, "author": "", "url": "https://www.reuters.com/article/us-monsanto-m-a-bayer/bayer-monsanto-deal-on-track-for-u-s-approval-by-end-of-may-source-idUSKBN1HX1UX", "ord_in_thread": 0, "title": "Bayer, Monsanto deal on track for U.S. approval by end of May -source", "locations": [], "entities": {"persons": [{"name": "diane bartz", "sentiment": "none"}, {"name": "susan heavey", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "new york city", "sentiment": "none"}, {"name": "washington", "sentiment": "none"}], "organizations": [{"name": "monsanto", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}, {"name": "new york stock exchange", "sentiment": "none"}, {"name": "bayer ag", "sentiment": "none"}, {"name": "nyse", "sentiment": "none"}, {"name": "monsanto co", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WASHINGTON (Reuters) - German drug and crop chemical maker Bayer AGâ€™s bid to buy seed and chemical company Monsanto Co is on track to win U.S. antitrust approval by the end of May, unless there is a last-minute complication, a source familiar with the matter said on Thursday.\nFILE PHOTO: Monsanto logo is displayed on a screen where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S. on May 9, 2016. REUTERS/Brendan McDermid/File Photo The transaction, if it closes as seems likely, will create a company commanding more than a quarter of the combined world market for seeds and pesticides in the fast-consolidating farm supplies industry.\nReporting by Diane Bartz; Editing by Susan Heavey\n ", "external_links": [], "published": "2018-04-26T15:01:00.000+03:00", "crawled": "2018-04-26T15:17:02.016+03:00", "highlightTitle": ""}